The Medicines Company (MDCO) PT Raised to $50 at Guggenheim
Tweet Send to a Friend
Guggenheim analyst Adnan Butt raised the price target on The Medicines Company (NASDAQ: MDCO) to $50.00 (from $45.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
